Dapagliflozin restores diabetes-associated decline in vasculogenic capacity of endothelial progenitor cells via activating AMPK-mediated inhibition of inflammation and oxidative stress
- Resource Type
- Short Communication
- Source
- In
Biochemical and Biophysical Research Communications 3 September 2023 671:205-214 - Subject
- Language
- ISSN
- 0006-291X